Long-acting reversible contraceptives: Not only effective, but also a cost-effective option for the National Health Service

Journal of Family Planning and Reproductive Health Care

Volumn 32, Issue 1, 2006, Pages 3-5

  Mavranezouli, Ifigeneia ^a   Wilkinson, Christopher ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Camden Primary Care Trust   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT;

ABORTION; COHORT ANALYSIS; CONDOM; CONSULTATION; COST EFFECTIVENESS ANALYSIS; DRUG UTILIZATION; ECTOPIC PREGNANCY; FAMILY PLANNING; FEMALE STERILIZATION; GENERAL PRACTITIONER; HEALTH CARE UTILIZATION; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MALE STERILIZATION; NOTE; ORAL CONTRACEPTION; PATIENT COMPLIANCE; PERCEPTION; SPONTANEOUS ABORTION; UNWANTED PREGNANCY; ADOLESCENT; ADULT; ARTICLE; COST; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; MIDDLE AGED; NATIONAL HEALTH SERVICE; UNITED KINGDOM;

ADOLESCENT; ADULT; CONTRACEPTIVE AGENTS, FEMALE; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; FEMALE; GREAT BRITAIN; HUMANS; MIDDLE AGED; STATE MEDICINE;

EID: 33645238956     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1783/147118906775275073     Document Type: Note

References (8)

1. National Collaborating Centre for Women's and Children's Health. Long-acting Reversible Contraception: The Effective and Appropriate Use of Long-acting Reversible Contraception. Guideline commissioned by the National Institute for Health and Clinical Excellence (NICE). London, UK: Royal College of Obstetricians and Gynaecologists Press, 2005. http://www.nice.org.uk/pdf/ CG030fullguideline.pdf [Accessed 28 October 2005].
2. Trussell J. Contraceptive efficacy. In: Hatcher RA, Trussell J, Stewart F, Nelson A, Cates W, Guest F, et al. (eds), Contraceptive Technology (18th edn). New York, NY: Ardent Media, 2004; 773-845.
3. Emans SJ, Grace E, Woods ER. Adolescents' compliance with the use of oral contraceptives. JAMA 1987; 257: 3377-3381.
4. Rosenberg MJ, Waugh MS, Meehan TE. Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation. Contraception 1995; 51: 283-288.
5. Dawe F, Rainsbury P. Contraception and Sexual Health, 2003. Office for National Statistics. London, UK: HMSO, 2004. http://www.dh.gov.uk/ PublicationsAndStatistics/Publications/Publica tionsStatistics/ PublicationsStatisticsArticle/fs/en?CONTENT_ID=40 90020&chk=Oh9XRb [Accessed 28 October 2005].
6. Office for National Statistics (ONS). T 03: England and Wales; Estimated Resident Population by Single Year of Age and Sex; Mid-2004 Population Estimates. http://www.statistics.gov.uk/statbase/ssdataset.asp?vlnk= 9084&More=Y [Accessed 2 November 2005].
7. Royal College of Obstetricians and Gynaecologists (RCOG). Male and Female Sterilisation (National Evidence-Based Clinical Guideline No. 4). London, UK: RCOG Press, 2004.
8. Hurskainen R, Teperi J, Rissanen P, Aalto A-M, Grenman S, Kivelä A, et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. JAMA 2004; 291: 1456-1463.